Raptor Pharmaceuticals Announces Completion of Patient Enrollment ... FOXBusiness - In the six-month, open-label clinical trial, UC San Diego enrolled a total of 12 adolescent NASH patients receiving a twice daily oral dose of cysteamine ... |
« Crucell Announces Profits for Full Year 2008 - CNNMoney.com | Main | Get a Deep Insight into the US Flavors & Fragrances Market - Earthtimes (press release) »
TrackBack URL for this entry:
http://www.typepad.com/services/trackback/6a00e54ed2f120883301116898e15e970c
Listed below are links to weblogs that reference Raptor Pharmaceuticals Announces Completion of Patient Enrollment ... - FOXBusiness:
This is only a preview. Your comment has not yet been posted.
As a final step before posting your comment, enter the letters and numbers you see in the image below. This prevents automated programs from posting comments.
Having trouble reading this image? View an alternate.
Comments